Resources Contact Us Home
Immunological composition of measles virus utilizing recombinant poxvirus

Image Number 12 for United States Patent #5759841.

What is described is a recombinant poxvirus, such as vaccinia virus or canarypox virus, containing foreign DNA from Morbillivirus. In one embodiment, the foreign DNA is expressed in a host by the production of a measles virus glycoprotein. In another embodiment, the foreign DNA is expressed in a host by the production of at least two measles virus glycoproteins. What is also described is a vaccine containing the recombinant poxvirus for inducing an immunological response in a host animal inoculated with the vaccine. By the present invention, cross-protection of dogs against canine distemper is obtained by inoculating the dog with the recombinant poxvirus.

  Recently Added Patents
System and method for transferring data in storage controllers
Dynamic rebasing of persisted time information
Platform for generating electricity from flowing fluid using generally prolate turbine
Virtual physician acute myocardial infarction detection system and method
Quinoline compounds and their use for treating viral infection
Charge pump and method of biasing deep N-well in charge pump
Upper surface of a skateboard deck
  Randomly Featured Patents
Phase lock loop with narrow band lock-in and wideband acquisition characteristics
Packaging box
Solder joint determination method, solder inspection method, and solder inspection device
Portable electronic typewriter
Antimicrobial composition containing a haloperoxidase, a hydrogen peroxide source, a halide source and an ammonium source
Tower of numeric types
Rigid needle shield
Method of forming a laterally expandable tampon
Direct-acting pressure regulator
On-line hierarchical form records identification